Back
Verve Therapeutics Vs. Prime Medicine Industry Stock Comparison
Sell
10
VERV
Verve Therapeutics
Last Price:
5.20
Seasonality Move:
66.08%
Sell
37
PRME
Prime Medicine
Last Price:
6.48
Seasonality Move:
-6.44%
Sell
10
Verve Therapeutics (VERV)
is a Sell
Is Verve Therapeutics a Buy, Sell or Hold?
- The current Verve Therapeutics [VERV] share price is $5.20. The Score for VERV is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
- VERV is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
37
Prime Medicine (PRME)
is a Sell
Is Prime Medicine a Buy, Sell or Hold?
- The current Prime Medicine [PRME] share price is $6.49. The Score for PRME is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- PRME is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VERV Stock Price Chart
What is Verve Therapeutics's stock price today?
-
The Verve Therapeutics share price today is $5.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VERV is experiencing slight buying pressure.
PRME Stock Price Chart
What is Prime Medicine's stock price today?
-
The Prime Medicine share price today is $6.49
The current trend is moderately bearish and PRME is experiencing slight selling pressure.
VERV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.64 | Sell |
| Relative Strength Index (14 RSI): | 28.17 | Sell |
| Chaikin Money Flow: | 378033 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.46 - 6.34) | Sell |
| Bollinger Bands (100): | (6.81 - 13.93) | Sell |
PRME Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 51.32 | Buy |
| Chaikin Money Flow: | -240563 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.3 - 7.12) | Buy |
| Bollinger Bands (100): | (5.59 - 7.95) | Sell |
VERV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.3 | Sell |
| 20-day SMA: | 5.84 | Sell |
| 50-day SMA: | 7.5 | Sell |
| 200-day SMA: | 11.53 | Sell |
| 8-day EMA: | 5.35 | Sell |
| 20-day EMA: | 5.84 | Sell |
| 50-day EMA: | 7.48 | Sell |
| 200-day EMA: | 11.75 | Sell |
PRME Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.92 | Sell |
| 20-day SMA: | 6.51 | Sell |
| 50-day SMA: | 6 | Buy |
| 200-day SMA: | 7.95 | Sell |
| 8-day EMA: | 6.7 | Sell |
| 20-day EMA: | 6.5 | Sell |
| 50-day EMA: | 6.39 | Buy |
| 200-day EMA: | 8.33 | Sell |
Verve Therapeutics Earnings Growth & VERV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.68 per share, and a decrease next year of $0.28 per share.
Prime Medicine Earnings Growth & PRME Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and an increase next year of $0.14 per share.
Verve Therapeutics Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Prime Medicine Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||